NO20091694L - Anvendelse av modifiserte cyklosporiner - Google Patents

Anvendelse av modifiserte cyklosporiner

Info

Publication number
NO20091694L
NO20091694L NO20091694A NO20091694A NO20091694L NO 20091694 L NO20091694 L NO 20091694L NO 20091694 A NO20091694 A NO 20091694A NO 20091694 A NO20091694 A NO 20091694A NO 20091694 L NO20091694 L NO 20091694L
Authority
NO
Norway
Prior art keywords
cyclosporins
modified
modified cyclosporins
contraception
treatment
Prior art date
Application number
NO20091694A
Other languages
English (en)
Norwegian (no)
Inventor
Motoyuki Kohjima
Makoto Nakamuta
Original Assignee
Univ Kyushu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyushu filed Critical Univ Kyushu
Publication of NO20091694L publication Critical patent/NO20091694L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20091694A 2006-10-12 2009-04-28 Anvendelse av modifiserte cyklosporiner NO20091694L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82922806P 2006-10-12 2006-10-12
PCT/EP2007/060794 WO2008043797A1 (en) 2006-10-12 2007-10-10 Use of modified cyclosporins

Publications (1)

Publication Number Publication Date
NO20091694L true NO20091694L (no) 2009-07-10

Family

ID=39092021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091694A NO20091694L (no) 2006-10-12 2009-04-28 Anvendelse av modifiserte cyklosporiner

Country Status (17)

Country Link
US (1) US20100130408A1 (ko)
EP (1) EP2073831A1 (ko)
JP (1) JP5455632B2 (ko)
KR (1) KR20090083902A (ko)
CN (1) CN101557819A (ko)
AU (1) AU2007306316B2 (ko)
BR (1) BRPI0719189A2 (ko)
CA (1) CA2665415A1 (ko)
IL (1) IL197966A0 (ko)
MA (1) MA30865B1 (ko)
MX (1) MX2009003743A (ko)
NO (1) NO20091694L (ko)
RU (1) RU2463071C2 (ko)
SG (1) SG175621A1 (ko)
TN (1) TN2009000135A1 (ko)
WO (1) WO2008043797A1 (ko)
ZA (1) ZA200902300B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110117055A1 (en) 2009-11-19 2011-05-19 Macdonald James E Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
CN101843893B (zh) * 2010-05-21 2012-02-01 中国人民解放军第三军医大学 环孢素a在制备抗轮状病毒药物中的应用
EP2576552A4 (en) * 2010-06-01 2013-11-13 Aupex Pharmaceutical Inc BENZOQUINOLONE INHIBITORS OF VMAT2
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
EP2897615A4 (en) 2012-09-18 2016-04-27 Auspex Pharmaceuticals Inc PHARMACOKINETIC FORMULATIONS OF DEUTERATED BENZOCHINOL INHIBITORS OF THE VESICLE MONOAMINE TRANSPORTER 2
EA032920B1 (ru) 2013-12-03 2019-08-30 Оспекс Фармасьютикалз, Инк. Способы получения соединений бензохинолина
SG11201706959TA (en) 2015-03-06 2017-09-28 Auspex Pharmaceuticals Inc Methods for the treatment of abnormal involuntary movement disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
DE69928938T2 (de) * 1998-07-01 2006-08-17 Debiopharm S.A. Neues cyclosporin mit verbesserter wirkung
JP4509395B2 (ja) * 1999-04-27 2010-07-21 田辺三菱製薬株式会社 肝臓疾患の予防治療薬
AU2001292301A1 (en) * 2000-10-11 2002-04-22 Daiichi Pharmaceutical Co., Ltd. Novel drugs for liver diseases
US20030213603A1 (en) * 2002-05-14 2003-11-20 Fisher David B. Dual use extension apparatus for a tool
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
US7079552B2 (en) * 2003-09-09 2006-07-18 Harris Corporation Mobile ad hoc network (MANET) with quality-of-service (QoS) protocol hierarchy and related methods
RS51614B (en) * 2004-10-01 2011-08-31 Debiopharm S.A. USE OF [D-MEAL] 3- [ETVAL] 4-CYCLOSPORINE FOR THE TREATMENT OF HEPATITIS C INFECTIONS
MX2007003538A (es) * 2004-10-01 2008-01-16 Scynexis Inc Derivados de ciclosporina 3-eter y 3-tioeter sustituidos para el tratamiento y prevencion de infeccion de hepatitis c.
AU2005322242B2 (en) * 2004-12-23 2010-02-11 Novartis Ag Compositions for HCV treatment
US8512690B2 (en) * 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors

Also Published As

Publication number Publication date
SG175621A1 (en) 2011-11-28
AU2007306316B2 (en) 2011-10-27
MX2009003743A (es) 2009-06-18
TN2009000135A1 (en) 2010-10-18
JP5455632B2 (ja) 2014-03-26
ZA200902300B (en) 2010-10-27
EP2073831A1 (en) 2009-07-01
BRPI0719189A2 (pt) 2018-08-14
RU2463071C2 (ru) 2012-10-10
JP2010505912A (ja) 2010-02-25
MA30865B1 (fr) 2009-11-02
AU2007306316A1 (en) 2008-04-17
WO2008043797A1 (en) 2008-04-17
CN101557819A (zh) 2009-10-14
KR20090083902A (ko) 2009-08-04
IL197966A0 (en) 2011-08-01
CA2665415A1 (en) 2008-04-17
RU2009117699A (ru) 2010-11-20
US20100130408A1 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
NO20091694L (no) Anvendelse av modifiserte cyklosporiner
CL2007002327A1 (es) Compuestos derivados de fenil-imidazol sustituido; composicion farmaceutica; y uso en el tratamiento del vhc.
TNSN06071A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
CL2009000200A1 (es) Compuestos derivados de 2,7-naftiridinas-1-ona, mediadores de syk; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria, respiratoria, proliferativa celular o autoinmune.
LTPA2017009I1 (lt) Brutono tirozinkinazės inhibitoriai
CL2008001303A1 (es) Compuestos derivados de heterociclos, moduladores de gamma secretasa; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento del alzheimer.
MX2008016453A (es) Composiciones y metodos para tratar infecciones parasitas.
TNSN07240A1 (en) Compounds for flaviviridae treatment
CL2007002261A1 (es) Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
EA200700725A1 (ru) ПРИМЕНЕНИЕ [D-MeAla]-[EtVal]-ЦИКЛОСПОРИНА ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИИ ГЕПАТИТА С И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ [D-MeAla]-[EtVal]-ЦИКЛОСПОРИН
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2008001122A1 (es) Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
CL2008001721A1 (es) Compuestos derivados de 17-beta-ciano-18 alfa-homo-19-nor-androst-4-eno; que presentan actividad gestagena y antimineralcorticoide; composicion farmaceutica; y uso en el tratamiento de trastornos pre-peri-y posmenopausicos y trastornos premenstruales.
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
UA98658C2 (uk) Циклічні депсипептиди
IL192373A (en) Arginine cyclic peptides and their use in the treatment of fungal infections
CL2008002411A1 (es) Compuestos derivados de heterociclos de nitrogenos;composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la miosina del musculo liso o la miosina no muscular, tales como hipertension, enfermedad pulmonar, glaucoma, apoplejia, enfermedades broncocontrictoras, entre otras.
ATE423114T1 (de) Aminocyclopropancarbonsäureamidderivate als bradykininantagonisten
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
CL2007003672A1 (es) Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad.
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
BRPI0811538A2 (pt) Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares.
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application